53 research outputs found
Integration of a specialist into the international space: linguistic training and cross cultural interaction
The article considers the possibilities of international internships for medical students and doctors. The problems of insufficient linguistic training of health care manpower for representing Russian Federation at the international level are discussed. Ways to work out these issues are suggested
ΠΡΠ΄ΠΈ Ρ ΠΎΠ³ΡΠ°Π½ΠΈΡΠ΅Π½Π½ΡΠΌΠΈ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΡΠΌΠΈ: Π°Π΄Π°ΠΏΡΠ°ΡΠΈΡ ΠΊ ΡΠΎΡΠΈΠ°Π»ΡΠ½ΠΎΠΉ ΡΡΠ΅Π΄Π΅
The article discusses the problems that people with disabilities face every day. Loneliness, misunderstanding, detachment, lack of money make such people unhappy. The article proposes the solution of many social issues, such as finding a job, government support, changing the attitude of ordinary people to people with disabilities, the formation of an inclusive society, the fight against discrimination, leisure activities. There are also examples of successful implementation of various projects and holding large-scale events in Yekaterinburg, such as Β«Accessible YekaterinburgΒ», the First World Congress for People with Disabilities in 2017, Β«Lessons of GoodnessΒ» in schools. This article reveals the problem of social adaptation of persons with disabilities, not only as a state, but also a public. It proves that only by joint efforts of the state and common citizens is it possible to make significant changes to the problem under discussion. Also, in this article there are examples of the real value of the equipment necessary for the daily life of people with disabilities. Today, despite the large number of changes in the social sphere, there are a large number of unresolved issues in improving the quality of life of people with disabilities.Π ΡΡΠ°ΡΡΠ΅ ΡΠ°ΡΡΠΌΠΎΡΡΠ΅Π½Ρ ΠΏΡΠΎΠ±Π»Π΅ΠΌΡ, Ρ ΠΊΠΎΡΠΎΡΡΠΌΠΈ ΠΈΠ½Π²Π°Π»ΠΈΠ΄Ρ ΡΡΠ°Π»ΠΊΠΈΠ²Π°ΡΡΡΡ ΠΊΠ°ΠΆΠ΄ΡΠΉ Π΄Π΅Π½Ρ. ΠΠ΄ΠΈΠ½ΠΎΡΠ΅ΡΡΠ²ΠΎ, Π½Π΅ΠΏΠΎΠ½ΠΈΠΌΠ°Π½ΠΈΠ΅, ΠΎΡΡΡΡΠ°Π½Π΅Π½Π½ΠΎΡΡΡ, Π½Π΅Ρ
Π²Π°ΡΠΊΠ° Π΄Π΅Π½Π΅Π³ Π΄Π΅Π»Π°ΡΡ ΡΠ°ΠΊΠΈΡ
Π»ΡΠ΄Π΅ΠΉ Π½Π΅ΡΡΠ°ΡΡΠ»ΠΈΠ²ΡΠΌΠΈ. Π ΡΡΠ°ΡΡΠ΅ ΠΏΡΠ΅Π΄Π»Π°Π³Π°Π΅ΡΡΡ ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ ΠΌΠ½ΠΎΠ³ΠΈΡ
ΡΠΎΡΠΈΠ°Π»ΡΠ½ΡΡ
Π²ΠΎΠΏΡΠΎΡΠΎΠ², ΡΠ°ΠΊΠΈΡ
ΠΊΠ°ΠΊ ΡΡΡΡΠΎΠΉΡΡΠ²ΠΎ Π½Π° ΡΠ°Π±ΠΎΡΡ, Π³ΠΎΡΡΠ΄Π°ΡΡΡΠ²Π΅Π½Π½Π°Ρ ΠΏΠΎΠ΄Π΄Π΅ΡΠΆΠΊΠ°, ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ ΠΎΡΠ½ΠΎΡΠ΅Π½ΠΈΡ ΠΎΠ±ΡΡΠ½ΡΡ
Π»ΡΠ΄Π΅ΠΉ ΠΊ Π»ΡΠ΄ΡΠΌ Ρ ΠΈΠ½Π²Π°Π»ΠΈΠ΄Π½ΠΎΡΡΡΡ, ΡΠΎΡΠΌΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ ΠΈΠ½ΠΊΠ»ΡΠ·ΠΈΠ²Π½ΠΎΠ³ΠΎ ΠΎΠ±ΡΠ΅ΡΡΠ²Π°, Π±ΠΎΡΡΠ±Π° Ρ Π΄ΠΈΡΠΊΡΠΈΠΌΠΈΠ½Π°ΡΠΈΠ΅ΠΉ, ΠΎΡΠ³Π°Π½ΠΈΠ·Π°ΡΠΈΡ Π΄ΠΎΡΡΠ³Π°. Π’Π°ΠΊΠΆΠ΅ ΠΈΠΌΠ΅ΡΡΡΡ ΠΏΡΠΈΠΌΠ΅ΡΡ ΡΡΠΏΠ΅ΡΠ½ΠΎΠ³ΠΎ Π²Π½Π΅Π΄ΡΠ΅Π½ΠΈΡ ΡΠ°Π·Π»ΠΈΡΠ½ΡΡ
ΠΏΡΠΎΠ΅ΠΊΡΠΎΠ² ΠΈ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΠ΅ ΠΌΠ°ΡΡΡΠ°Π±Π½ΡΡ
ΠΌΠ΅ΡΠΎΠΏΡΠΈΡΡΠΈΠΉ Π² ΠΠΊΠ°ΡΠ΅ΡΠΈΠ½Π±ΡΡΠ³Π΅, ΡΠ°ΠΊΠΈΡ
ΠΊΠ°ΠΊ Β«ΠΠΎΡΡΡΠΏΠ½ΡΠΉ ΠΠΊΠ°ΡΠ΅ΡΠΈΠ½Π±ΡΡΠ³Β», ΠΠ΅ΡΠ²ΡΠΉ ΠΡΠ΅ΠΌΠΈΡΠ½ΡΠΉ ΠΊΠΎΠ½Π³ΡΠ΅ΡΡ Π΄Π»Ρ Π»ΡΠ΄Π΅ΠΉ Ρ ΠΈΠ½Π²Π°Π»ΠΈΠ΄Π½ΠΎΡΡΡΡ Π² 2017 Π³ΠΎΠ΄Ρ, Β«Π£ΡΠΎΠΊΠΈ Π΄ΠΎΠ±ΡΠ°Β» Π² ΡΠΊΠΎΠ»Π°Ρ
. ΠΠ°Π½Π½Π°Ρ ΡΡΠ°ΡΡΡ ΡΠ°ΡΠΊΡΡΠ²Π°Π΅Ρ ΠΏΡΠΎΠ±Π»Π΅ΠΌΡ ΡΠΎΡΠΈΠ°Π»ΡΠ½ΠΎΠΉ Π°Π΄Π°ΠΏΡΠ°ΡΠΈΠΈ ΠΈΠ½Π²Π°Π»ΠΈΠ΄ΠΎΠ² Π½Π΅ ΡΠΎΠ»ΡΠΊΠΎ ΠΊΠ°ΠΊ Π³ΠΎΡΡΠ΄Π°ΡΡΡΠ²Π΅Π½Π½ΡΡ, Π½ΠΎ ΠΈ ΠΎΠ±ΡΠ΅ΡΡΠ²Π΅Π½Π½ΡΡ. ΠΠ½Π° Π΄ΠΎΠΊΠ°Π·ΡΠ²Π°Π΅Ρ, ΡΡΠΎ ΡΠΎΠ»ΡΠΊΠΎ ΡΠΎΠ²ΠΌΠ΅ΡΡΠ½ΡΠΌΠΈ ΡΡΠΈΠ»ΠΈΡΠΌΠΈ Π³ΠΎΡΡΠ΄Π°ΡΡΡΠ²Π° ΠΈ ΠΎΠ±ΡΡΠ½ΡΡ
ΠΆΠΈΡΠ΅Π»Π΅ΠΉ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎ Π²Π½Π΅ΡΡΠΈ ΡΡΡΠ΅ΡΡΠ²Π΅Π½Π½ΡΠ΅ ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΡ Π² ΠΎΠ±ΡΡΠΆΠ΄Π°Π΅ΠΌΡΡ ΠΏΡΠΎΠ±Π»Π΅ΠΌΡ. Π’Π°ΠΊΠΆΠ΅ Π² ΡΡΠΎΠΉ ΡΡΠ°ΡΡΠ΅ ΠΈΠΌΠ΅ΡΡΡΡ ΠΏΡΠΈΠΌΠ΅ΡΡ ΡΠ΅Π°Π»ΡΠ½ΠΎΠΉ ΡΡΠΎΠΈΠΌΠΎΡΡΠΈ ΠΈΠ½Π²Π΅Π½ΡΠ°ΡΡ, Π½Π΅ΠΎΠ±Ρ
ΠΎΠ΄ΠΈΠΌΠΎΠ³ΠΎ Π΄Π»Ρ ΠΏΠΎΠ²ΡΠ΅Π΄Π½Π΅Π²Π½ΠΎΠΉ ΠΆΠΈΠ·Π½ΠΈ Π»ΡΠ΄Π΅ΠΉ Ρ ΠΈΠ½Π²Π°Π»ΠΈΠ΄Π½ΠΎΡΡΡΡ. ΠΠ° ΡΠ΅Π³ΠΎΠ΄Π½ΡΡΠ½ΠΈΠΉ Π΄Π΅Π½Ρ, Π½Π΅ΡΠΌΠΎΡΡΡ Π½Π° Π±ΠΎΠ»ΡΡΠΎΠ΅ ΡΠΈΡΠ»ΠΎ ΠΏΠ΅ΡΠ΅ΠΌΠ΅Π½ Π² ΡΠΎΡΠΈΠ°Π»ΡΠ½ΠΎΠΉ ΡΡΠ΅ΡΠ΅, ΠΈΠΌΠ΅Π΅ΡΡΡ Π±ΠΎΠ»ΡΡΠΎΠ΅ ΠΊΠΎΠ»ΠΈΡΠ΅ΡΡΠ²ΠΎ Π½Π΅ΡΠ΅ΡΠ΅Π½Π½ΡΡ
Π²ΠΎΠΏΡΠΎΡΠΎΠ² Π² ΡΠ»ΡΡΡΠ΅Π½ΠΈΠΈ ΠΊΠ°ΡΠ΅ΡΡΠ²Π° ΠΆΠΈΠ·Π½ΠΈ Π»ΡΠ΄Π΅ΠΉ Ρ ΠΈΠ½Π²Π°Π»ΠΈΠ΄Π½ΠΎΡΡΡΡ
C9orf16 (BBLN) gene, encoding a member of Hero proteins, is a novel marker in ischemic stroke risk
To investigate an association between a single nucleotide polymorphism rs2900262 in the gene encoding C9orf16 and predisposition to I
Follow-up stadies patients undergoing legionnairesβ disease during epidemic outbreak of legionellosis in the Sverdlovsk region
For the first time described the sustainability of clinical symptoms, laboratory, ECG and radiographic changes, assess the quality of life due to health within the follow-up study of non-small but well defined group of 46 patients who suffered legionnaires' disease (LD) during epidemic outbreaks of legionellosis in the Sverdlovsk Oblast. The most prevalent and persistent clinical symptoms at 12 months had a cough and increased blood pressure. According to the results of studies conducted in patients undergoing LD, 1 year after hospital discharge, it should be noted: the preservation of normative values of red blood cells and hemoglobin level, normalizing the number of leukocytes, neutrophils, lymphocytes, and erythrocyte sedimentation rate, absence of "freshβ electrocardiography and radiographic changes, the transitory nature of the relative reliability of thrombocytosis and the syndrome of hepatocyte cytolysis. Quality of life was significantly disrupted in three of the eight indicators, as assessed by SF-36 form, and is due to reduced levels of physical activity in male patients, the increase in subjec-tive pain, decline in social relationships and social activity, with a one-time increase the viability and reduced anxiety and restlessness. The results of our study suggest that the medical work-ship should be aware of possible manifestations of persistent symptoms, at breach of the quality of life due to health, especially in the situation of the epidemic, as patients will turn to them for help. Awareness of these issues will help provide more quality in the power of such patients. Thus, the legionnaires' disease can have a negative impact on with-standing health most patients for at least 12 months after discharge from the hospital.ΠΠΏΠ΅ΡΠ²ΡΠ΅ ΠΎΠΏΠΈΡΠ°Π½Π° ΡΡΡΠΎΠΉΡΠΈΠ²ΠΎΡΡΡ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΠΈΠΌΠΏΡΠΎΠΌΠΎΠ², Π»Π°Π±ΠΎΡΠ°ΡΠΎΡΠ½ΡΡ
, ΡΠ»Π΅ΠΊΡΡΠΎΠΊΠ°ΡΠ΄ΠΈΠΎΠ³ΡΠ°ΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΈ ΡΠ΅Π½ΡΠ³Π΅Π½ΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΠΉ, Π΄Π°Π½Π° ΠΎΡΠ΅Π½ΠΊΠ° ΠΊΠ°ΡΠ΅ΡΡΠ²Π° ΠΆΠΈΠ·Π½ΠΈ, ΠΎΠ±ΡΡΠ»ΠΎΠ²Π»Π΅Π½Π½ΠΎΠ³ΠΎ ΡΠΎΡΡΠΎΡΠ½ΠΈΠ΅ΠΌ Π·Π΄ΠΎΡΠΎΠ²ΡΡ Π² ΡΠ°ΠΌΠΊΠ°Ρ
ΠΊΠ°ΡΠ°ΠΌΠ½Π΅ΡΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ Π½Π΅Π±ΠΎΠ»ΡΡΠΎΠΉ, Π½ΠΎ ΡΠ΅ΡΠΊΠΎ ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½Π½ΠΎΠΉ Π³ΡΡΠΏΠΏΡ ΠΈΠ· 46 ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ², ΠΊΠΎΡΠΎΡΡΠ΅ ΠΏΠ΅ΡΠ΅Π½Π΅ΡΠ»ΠΈ Π»Π΅Π³ΠΈΠΎΠ½Π΅Π»Π»Π΅Π·Π½ΡΡ ΠΏΠ½Π΅Π²ΠΌΠΎΠ½ΠΈΡ (Π―Π) Π²ΠΎ Π²ΡΠ΅ΠΌΡ ΡΠΏΠΈΠ΄Π΅ΠΌΠΈΡΠ΅ΡΠΊΠΎΠΉ Π²ΡΠΏΡΡΠΊΠΈ Π»Π΅Π³ΠΈΠΎΠ½Π΅Π»Π»Π΅Π·Π° Π² Π‘Π²Π΅ΡΠ΄Π»ΠΎΠ²ΡΠΊΠΎΠΉ ΠΎΠ±Π»Π°ΡΡΠΈ. ΠΠ°ΠΈΠ±ΠΎΠ»Π΅Π΅ ΡΠ°ΡΠΏΡΠΎΡΡΡΠ°Π½Π΅Π½Π½ΡΠΌΠΈ ΠΈ ΡΡΡΠΎΠΉΡΠΈΠ²ΡΠΌΠΈ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ ΡΠΈΠΌΠΏΡΠΎΠΌΠ°ΠΌΠΈ ΡΠ΅ΡΠ΅Π· 12 ΠΌΠ΅ΡΡΡΠ΅Π² Π±ΡΠ»ΠΈ ΠΊΠ°ΡΠ΅Π»Ρ ΠΈ ΠΏΠΎΠ²ΡΡΠ΅Π½ΠΈΠ΅ ΡΡΠΎΠ²Π½Ρ Π°ΡΡΠ΅ΡΠΈΠ°Π»ΡΠ½ΠΎΠ³ΠΎ Π΄Π°Π²Π»Π΅Π½ΠΈΡ. ΠΠΎ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠ°ΠΌ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΉ, ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½Π½ΡΡ
Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ², ΠΏΠ΅ΡΠ΅Π½Π΅ΡΡΠΈΡ
Π―Π, ΡΠ΅ΡΠ΅Π· 1 Π³ΠΎΠ΄ ΠΏΠΎΡΠ»Π΅ Π²ΡΠΏΠΈΡΠΊΠΈ ΠΈΠ· ΡΡΠ°ΡΠΈΠΎΠ½Π°ΡΠ°, ΡΠ»Π΅Π΄ΡΠ΅Ρ ΠΎΡΠΌΠ΅ΡΠΈΡΡ: ΡΠΎΡ
ΡΠ°Π½Π΅Π½ΠΈΠ΅ Π½ΠΎΡΠΌΠ°ΡΠΈΠ²Π½ΡΡ
Π·Π½Π°ΡΠ΅Π½ΠΈΠΉ ΡΠΈΡΠ»Π° ΡΡΠΈΡΡΠΎΡΠΈΡΠΎΠ² ΠΈ ΡΡΠΎΠ²Π½Ρ Π³Π΅ΠΌΠΎΠ³Π»ΠΎΠ±ΠΈΠ½Π°; Π½ΠΎΡΠΌΠ°Π»ΠΈΠ·Π°ΡΠΈΡ ΠΊΠΎΠ»ΠΈΡΠ΅ΡΡΠ²Π° Π»Π΅ΠΉΠΊΠΎΡΠΈΡΠΎΠ², Π½Π΅ΠΉΡΡΠΎΡΠΈΠ»ΠΎΠ², Π»ΠΈΠΌΡΠΎΡΠΈΡΠΎΠ² ΠΈ Π‘ΠΠ; ΠΎΡΡΡΡΡΡΠ²ΠΈΠ΅ Β«ΡΠ²Π΅ΠΆΠΈΡ
Β» ΡΠ»Π΅ΠΊΡΡΠΎΠΊΠ°ΡΠ΄ΠΈΠΎΠ³ΡΠ°ΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΈ ΡΠ΅Π½ΡΠ³Π΅Π½ΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΠΉ; Π΄ΠΎΡΡΠΎΠ²Π΅ΡΠ½ΠΎΡΡΡ ΠΏΡΠ΅Ρ
ΠΎΠ΄ΡΡΠ΅Π³ΠΎ Ρ
Π°ΡΠ°ΠΊΡΠ΅ΡΠ° ΠΎΡΠ½ΠΎΡΠΈΡΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ ΡΡΠΎΠΌΠ±ΠΎΡΠΈΡΠΎΠ·Π° ΠΈ ΡΠΈΠ½Π΄ΡΠΎΠΌΠ° ΡΠΈΡΠΎΠ»ΠΈΠ·Π° Π³Π΅ΠΏΠ°ΡΠΎΡΠΈΡΠΎΠ². ΠΠ°ΡΠ΅ΡΡΠ²ΠΎ ΠΆΠΈΠ·Π½ΠΈ Π±ΡΠ»ΠΎ Π² Π·Π½Π°ΡΠΈΡΠ΅Π»ΡΠ½ΠΎΠΉ ΡΡΠ΅ΠΏΠ΅Π½ΠΈ Π½Π°ΡΡΡΠ΅Π½ΠΎ ΠΏΠΎ ΡΡΠ΅ΠΌ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΡΠΌ ΠΈΠ· Π²ΠΎΡΡΠΌΠΈ, ΠΎΡΠ΅Π½ΠΈΠ²Π°Π΅ΠΌΡΠΌ ΠΏΠΎ ΡΠΎΡΠΌΠ΅ SF-36, ΠΈ ΠΎΠ±ΡΡΠ»ΠΎΠ²Π»Π΅Π½ΠΎ ΡΠ½ΠΈΠΆΠ΅Π½ΠΈΠ΅ΠΌ ΡΡΠΎΠ²Π½Ρ ΡΠΈΠ·ΠΈΡΠ΅ΡΠΊΠΎΠΉ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² ΠΌΡΠΆΡΠΈΠ½; ΡΠ²Π΅Π»ΠΈΡΠ΅Π½ΠΈΠ΅ΠΌ ΠΎΠ±ΡΠ΅ΠΌΠ° ΡΡΠ±ΡΠ΅ΠΊΡΠΈΠ²Π½ΡΡ
Π±ΠΎΠ»Π΅Π²ΡΡ
ΠΎΡΡΡΠ΅Π½ΠΈΠΉ, ΡΠΌΠ΅Π½ΡΡΠ΅Π½ΠΈΠ΅ΠΌ ΠΎΠ±ΡΠ΅ΠΌΠ° ΡΠΎΡΠΈΠ°Π»ΡΠ½ΡΡ
ΡΠ²ΡΠ·Π΅ΠΉ ΠΈ ΡΠΎΡΠΈΠ°Π»ΡΠ½ΠΎΠΉ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ, Ρ ΠΎΠ΄Π½ΠΎΠ²ΡΠ΅ΠΌΠ΅Π½Π½ΡΠΌ ΡΠ²Π΅Π»ΠΈΡΠ΅Π½ΠΈΠ΅ΠΌ ΠΆΠΈΠ·Π½Π΅ΡΠΏΠΎΡΠΎΠ±Π½ΠΎΡΡΠΈ ΠΈ ΡΠ½ΠΈΠΆΠ΅Π½ΠΈΠ΅ΠΌ ΡΡΠ΅Π²ΠΎΠΆΠ½ΠΎΡΡΠΈ ΠΈ Π±Π΅ΡΠΏΠΎΠΊΠΎΠΉΡΡΠ²Π°. Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ Π½Π°ΡΠ΅Π³ΠΎ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ ΡΠ²ΠΈΠ΄Π΅ΡΠ΅Π»ΡΡΡΠ²ΡΡΡ ΠΎ ΡΠΎΠΌ, ΡΡΠΎ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΈΠ΅ ΡΠ°Π±ΠΎΡΠ½ΠΈΠΊΠΈ Π΄ΠΎΠ»ΠΆΠ½Ρ Π±ΡΡΡ ΠΎΡΠ²Π΅Π΄ΠΎΠΌΠ»Π΅Π½Ρ ΠΎ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΠΈ ΠΏΡΠΎΡΠ²Π»Π΅Π½ΠΈΡ ΡΡΡΠΎΠΉΡΠΈΠ²ΡΡ
ΡΠΈΠΌΠΏΡΠΎΠΌΠΎΠ², Π½Π°ΡΡΡΠ΅Π½ΠΈΡ ΠΊΠ°ΡΠ΅ΡΡΠ²Π° ΠΆΠΈΠ·Π½ΠΈ, ΠΎΠ±ΡΡΠ»ΠΎΠ²Π»Π΅Π½Π½ΠΎΠ³ΠΎ ΡΠΎΡΡΠΎΡΠ½ΠΈΠ΅ΠΌ Π·Π΄ΠΎΡΠΎΠ²ΡΡ, ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎ Π² ΡΠΈΡΡΠ°ΡΠΈΠΈ ΡΠΏΠΈΠ΄Π΅ΠΌΠΈΠΈ, ΠΏΠΎΡΠΊΠΎΠ»ΡΠΊΡ ΠΏΠ°ΡΠΈΠ΅Π½ΡΡ Π±ΡΠ΄ΡΡ ΠΎΠ±ΡΠ°ΡΠ°ΡΡΡΡ ΠΊ Π½ΠΈΠΌ Π·Π° ΠΏΠΎΠΌΠΎΡΡΡ Ρ ΠΏΠΎΠ΄ΠΎΠ±Π½ΡΠΌΠΈ ΠΆΠ°Π»ΠΎΠ±Π°ΠΌΠΈ. ΠΡΠ²Π΅Π΄ΠΎΠΌΠ»Π΅Π½Π½ΠΎΡΡΡ Π² ΡΡΠΈΡ
Π²ΠΎΠΏΡΠΎΡΠ°Ρ
ΠΏΠΎΠΌΠΎΠΆΠ΅Ρ ΠΎΠΊΠ°Π·Π°ΡΡ Π±ΠΎΠ»Π΅Π΅ ΠΊΠ°ΡΠ΅ΡΡΠ²Π΅Π½Π½ΡΡ ΠΏΠΎΠΌΠΎΡΡ ΡΠ°ΠΊΠΈΠΌ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠ°ΠΌ. Π’Π°ΠΊΠΈΠΌ ΠΎΠ±ΡΠ°Π·ΠΎΠΌ, Π±ΠΎΠ»Π΅Π·Π½Ρ Π»Π΅Π³ΠΈΠΎΠ½Π΅ΡΠΎΠ² ΠΌΠΎΠΆΠ΅Ρ ΠΎΠΊΠ°Π·ΡΠ²Π°ΡΡ Π½Π΅Π³Π°ΡΠΈΠ²Π½ΠΎΠ΅ Π²Π»ΠΈΡΠ½ΠΈΠ΅ Π½Π° ΡΠΎΡΡΠΎΡΠ½ΠΈΠ΅ Π·Π΄ΠΎΡΠΎΠ²ΡΡ Π±ΠΎΠ»ΡΡΠΎΠΉ ΡΠ°ΡΡΠΈ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Π½Π° ΠΏΡΠΎΡΡΠΆΠ΅Π½ΠΈΠΈ, ΠΏΠΎ ΠΌΠ΅Π½ΡΡΠ΅ΠΉ ΠΌΠ΅ΡΠ΅, 12 ΠΌΠ΅ΡΡΡΠ΅Π² ΠΏΠΎΡΠ»Π΅ Π²ΡΠΏΠΈΡΠΊΠΈ ΠΈΠ· ΡΡΠ°ΡΠΈΠΎΠ½Π°ΡΠ°
Modern ideas about the ferrokinetics features in the human body
This article is devoted to the problem of absorption of Fe+2 and Fe+3 ions that provide vital functions of the body. The article considers various ways of iron absorption carried out by numerous protein transporters, and notes their specialization in the assimilation of a certain ion.ΠΠ°Π½Π½Π°Ρ ΡΡΠ°ΡΡΡ ΠΏΠΎΡΠ²ΡΡΠ΅Π½Π° ΠΏΡΠΎΠ±Π»Π΅ΠΌΠ΅ Π²ΡΠ°ΡΡΠ²Π°Π½ΠΈΡ ΠΈΠΎΠ½ΠΎΠ² Fe+2 ΠΈ Fe+3, ΠΎΠ±Π΅ΡΠΏΠ΅ΡΠΈΠ²Π°ΡΡΠΈΡ
ΠΆΠΈΠ·Π½Π΅Π½Π½ΠΎ Π½Π΅ΠΎΠ±Ρ
ΠΎΠ΄ΠΈΠΌΡΠ΅ ΡΡΠ½ΠΊΡΠΈΠΈ ΠΎΡΠ³Π°Π½ΠΈΠ·ΠΌΠ°. Π ΡΡΠ°ΡΡΠ΅ ΡΠ°ΡΡΠΌΠΎΡΡΠ΅Π½Ρ ΡΠ°Π·Π»ΠΈΡΠ½ΡΠ΅ ΠΏΡΡΠΈ Π°Π±ΡΠΎΡΠ±ΡΠΈΠΈ ΠΆΠ΅Π»Π΅Π·Π°, ΠΎΡΡΡΠ΅ΡΡΠ²Π»ΡΠ΅ΠΌΡΠ΅ ΠΌΠ½ΠΎΠ³ΠΎΡΠΈΡΠ»Π΅Π½Π½ΡΠΌΠΈ Π±Π΅Π»ΠΊΠ°ΠΌΠΈ ΡΡΠ°Π½ΡΠΏΠΎΡΡΠ΅ΡΠ°ΠΌΠΈ, ΠΈ ΠΎΡΠΌΠ΅ΡΠ΅Π½Π° ΠΈΡ
ΡΠΏΠ΅ΡΠΈΠ°Π»ΠΈΠ·Π°ΡΠΈΡ Π½Π° ΡΡΠ²ΠΎΠ΅Π½ΠΈΠ΅ ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½Π½ΠΎΠ³ΠΎ ΠΈΠΎΠ½
ΠΡΠΎΠ³Π½ΠΎΡΡΠΈΡΠ΅ΡΠΊΠΎΠ΅ Π·Π½Π°ΡΠ΅Π½ΠΈΠ΅ ΠΌΠ°ΡΡΠΈΠΊΡΠ½ΡΡ ΠΌΠ΅ΡΠ°Π»Π»ΠΎΠΏΡΠΎΡΠ΅ΠΈΠ½Π°Π· Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ Π°Π½ΡΡΠ°ΡΠΈΠΊΠ»ΠΈΠ½ΠΈΠ½Π΄ΡΡΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠΉ ΡΠ΅ΡΠ΄Π΅ΡΠ½ΠΎΠΉ Π½Π΅Π΄ΠΎΡΡΠ°ΡΠΎΡΠ½ΠΎΡΡΡΡ
Highlights. Elevated levels of matrix metalloproteinases 2 and 9 are associated with the initiation and severity of CHF developed after breast cancer therapy with anthracyclines, which may contribute to cardiac remodeling and the progression of systolic dysfunction. Concentrations of matrix metalloproteinases-2 and -9 in blood serum serve as predictors of the unfavorable course of anthracycline-induced heart failure.Aim. To assess the role of matrix metalloproteinases-2 (MMP-2) and 9 (MMP-9) in the development and course of anthracycline-induced chronic heart failure (CHF) during 24 months of observation.Methods. The study included 114 women 12 months after completion of chemotherapy (CT) for breast cancer and developed CHF. The control group (n = 70) consisted of women (mean age 45.0 [42.0; 50.0] years old) who received doxorubicin as part of chemotherapy, but they did not develop CHF 12 months after completion of chemotherapy. The levels of biomarkers (MMP-2, MMP-9, NT-proBNP) in blood serum were determined using a sandwich immunoassay.Results. Patients with CHF had signs of cardiac remodeling and higher values of NT-proBNP, MMP-2 and MMP-9 (p<0.001) than women from the control group. After 24 months of observation, all patients with CHF were divided into 2 groups: group 1 β women with an unfavorable course of CHF (n = 54), group 2 β women with favorable course of pathology (n = 60). Criteria for the unfavorable course of CHF: the emergence of new or worsening of existing symptoms/signs of heart failure; and/or hospitalization due to HF decompensation; decrease in left ventricular ejection fraction by more than 10%; or an increase in the functional class of CHF by 1 or more. Baseline echocardiographic parameters and NT-proBNP values did not differ in groups 1 and 2. Levels of MMP-2 were higher by 8% (p = 0.017) and MMP-9 by 18.4% (p<0.001) in group 1. In 1 group the level of MMP-2 decreased after 24 months of observation. In group 2 the level of MMP-2 increased by the end of the observation period. MMP-2 levels β₯388.2 pg/ml (sensitivity 46%, specificity 80%; AUC = 0.64; p = 0.013) and MMP-9 β₯21.3 pg/ml (sensitivity 86%, specificity 84.4%; AUC = 0.9; p<0.001) were determined as predictors of an unfavorable course of CHF.Conclusion. Remodeling of the extracellular matrix may play an important role in the pathogenesis of CHF initiated by drugs of the anthracycline class. Elevated levels of MMP-2 and MMP-9 in the blood serum are associated with an unfavorable course of anthracycline-induced CHF and can be recommended when assessing the risk of an unfavorable course of pathology.ΠΡΠ½ΠΎΠ²Π½ΡΠ΅ ΠΏΠΎΠ»ΠΎΠΆΠ΅Π½ΠΈΡ. ΠΠΎΠ²ΡΡΠ΅Π½Π½ΡΠ΅ ΡΡΠΎΠ²Π½ΠΈ ΠΌΠ°ΡΡΠΈΠΊΡΠ½ΡΡ
ΠΌΠ΅ΡΠ°Π»Π»ΠΎΠΏΡΠΎΡΠ΅ΠΈΠ½Π°Π· 2 ΠΈ 9 Π°ΡΡΠΎΡΠΈΠΈΡΠΎΠ²Π°Π½Ρ Ρ ΠΈΠ½ΠΈΡΠΈΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ ΠΈ ΡΡΠΆΠ΅ΡΡΡΡ Π₯Π‘Π, ΡΠ°Π·Π²ΠΈΠ²ΡΠ΅ΠΉΡΡ ΠΏΠΎΡΠ»Π΅ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ ΡΠ°ΠΊΠ° ΠΌΠΎΠ»ΠΎΡΠ½ΠΎΠΉ ΠΆΠ΅Π»Π΅Π·Ρ Π°Π½ΡΡΠ°ΡΠΈΠΊΠ»ΠΈΠ½Π°ΠΌΠΈ, ΡΡΠΎ ΠΌΠΎΠΆΠ΅Ρ ΡΠΏΠΎΡΠΎΠ±ΡΡΠ²ΠΎΠ²Π°ΡΡ ΡΠ΅ΠΌΠΎΠ΄Π΅Π»ΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΡΠ΅ΡΠ΄ΡΠ° ΠΈ ΠΏΡΠΎΠ³ΡΠ΅ΡΡΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΡΠΈΡΡΠΎΠ»ΠΈΡΠ΅ΡΠΊΠΎΠΉ Π΄ΠΈΡΡΡΠ½ΠΊΡΠΈΠΈ. ΠΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΠΈ ΠΌΠ°ΡΡΠΈΠΊΡΠ½ΡΡ
ΠΌΠ΅ΡΠ°Π»Π»ΠΎΠΏΡΠΎΡΠ΅ΠΈΠ½Π°Π· 2 ΠΈ 9 Π² ΡΡΠ²ΠΎΡΠΎΡΠΊΠ΅ ΠΊΡΠΎΠ²ΠΈ ΡΠ»ΡΠΆΠ°Ρ ΠΏΡΠ΅Π΄ΠΈΠΊΡΠΎΡΠ°ΠΌΠΈ Π½Π΅Π±Π»Π°Π³ΠΎΠΏΡΠΈΡΡΠ½ΠΎΠ³ΠΎ ΡΠ΅ΡΠ΅Π½ΠΈΡ Π°Π½ΡΡΠ°ΡΠΈΠΊΠ»ΠΈΠ½ΠΈΠ½Π΄ΡΡΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠΉ ΡΠ΅ΡΠ΄Π΅ΡΠ½ΠΎΠΉ Π½Π΅Π΄ΠΎΡΡΠ°ΡΠΎΡΠ½ΠΎΡΡΠΈ.Π¦Π΅Π»Ρ. ΠΡΠ΅Π½ΠΈΡΡ ΡΠΎΠ»Ρ ΠΌΠ°ΡΡΠΈΠΊΡΠ½ΡΡ
ΠΌΠ΅ΡΠ°Π»Π»ΠΎΠΏΡΠΎΡΠ΅ΠΈΠ½Π°Π· 2 (ΠΠΠ-2) ΠΈ 9 (ΠΠΠ-9) Π² ΡΠ°Π·Π²ΠΈΡΠΈΠΈ ΠΈ ΡΠ΅ΡΠ΅Π½ΠΈΠΈ Π°Π½ΡΡΠ°ΡΠΈΠΊΠ»ΠΈΠ½ΠΈΠ½Π΄ΡΡΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠΉ Ρ
ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΠ΅ΡΠ΄Π΅ΡΠ½ΠΎΠΉ Π½Π΅Π΄ΠΎΡΡΠ°ΡΠΎΡΠ½ΠΎΡΡΠΈ (Π₯Π‘Π) Π² ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ 24 ΠΌΠ΅Ρ. Π½Π°Π±Π»ΡΠ΄Π΅Π½ΠΈΡ.ΠΠ°ΡΠ΅ΡΠΈΠ°Π»Ρ ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ. Π ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ Π²ΠΊΠ»ΡΡΠ΅Π½Ρ 114 ΠΆΠ΅Π½ΡΠΈΠ½ Ρ ΡΠ°Π·Π²ΠΈΠ²ΡΠ΅ΠΉΡΡ ΡΠ΅ΡΠ΅Π· 12 ΠΌΠ΅Ρ. ΠΏΠΎΡΠ»Π΅ Π·Π°Π²Π΅ΡΡΠ΅Π½ΠΈΡ Ρ
ΠΈΠΌΠΈΠΎΡΠ΅ΡΠ°ΠΏΠΈΠΈ ΠΏΠΎ ΠΏΠΎΠ²ΠΎΠ΄Ρ ΡΠ°ΠΊΠ° ΠΌΠΎΠ»ΠΎΡΠ½ΠΎΠΉ ΠΆΠ΅Π»Π΅Π·Ρ Π₯Π‘Π. ΠΠΎΠ½ΡΡΠΎΠ»ΡΠ½ΡΡ Π³ΡΡΠΏΠΏΡ (n = 70) ΡΠΎΡΡΠ°Π²ΠΈΠ»ΠΈ ΠΆΠ΅Π½ΡΠΈΠ½Ρ (ΡΡΠ΅Π΄Π½ΠΈΠΉ Π²ΠΎΠ·ΡΠ°ΡΡ 45,0 [42,0; 50,0] Π»Π΅Ρ), ΠΊΠΎΡΠΎΡΡΠ΅ ΠΏΠΎΠ»ΡΡΠ°Π»ΠΈ Π΄ΠΎΠΊΡΠΎΡΡΠ±ΠΈΡΠΈΠ½, Π½ΠΎ Ρ Π½ΠΈΡ
Π½Π΅ ΡΠ°Π·Π²ΠΈΠ»Π°ΡΡ Π₯Π‘Π ΡΠ΅ΡΠ΅Π· 12 ΠΌΠ΅Ρ. ΠΏΠΎΡΠ»Π΅ Ρ
ΠΈΠΌΠΈΠΎΡΠ΅ΡΠ°ΠΏΠΈΠΈ. Π£ΡΠΎΠ²Π½ΠΈ Π±ΠΈΠΎΠΌΠ°ΡΠΊΠ΅ΡΠΎΠ² (ΠΠΠ-2, ΠΠΠ-9, ΠΏΡΠ΅Π΄ΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΈΠΊΠ° ΠΌΠΎΠ·Π³ΠΎΠ²ΠΎΠ³ΠΎ Π½Π°ΡΡΠΈΠΉΡΡΠ΅ΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΏΠ΅ΠΏΡΠΈΠ΄Π° (NT-proBNP)) Π² ΡΡΠ²ΠΎΡΠΎΡΠΊΠ΅ ΠΊΡΠΎΠ²ΠΈ ΠΎΠΏΡΠ΅Π΄Π΅Π»ΡΠ»ΠΈ Ρ ΠΏΠΎΠΌΠΎΡΡΡ ΡΡΠ½Π΄Π²ΠΈΡ-ΠΈΠΌΠΌΡΠ½ΠΎΠ°Π½Π°Π»ΠΈΠ·Π°.Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. ΠΠΎΠ»ΡΠ½ΡΠ΅ Π₯Π‘Π ΠΈΠΌΠ΅Π»ΠΈ ΠΏΡΠΈΠ·Π½Π°ΠΊΠΈ ΡΠ΅ΠΌΠΎΠ΄Π΅Π»ΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΡΠ΅ΡΠ΄ΡΠ° ΠΈ Π±ΠΎΠ»Π΅Π΅ Π²ΡΡΠΎΠΊΠΈΠ΅ Π·Π½Π°ΡΠ΅Π½ΠΈΡ NT-proBNP, MMΠ-2 ΠΈ MMΠ-9 (p<0,001), ΡΠ΅ΠΌ ΠΆΠ΅Π½ΡΠΈΠ½Ρ ΠΈΠ· ΠΊΠΎΠ½ΡΡΠΎΠ»ΡΠ½ΠΎΠΉ Π³ΡΡΠΏΠΏΡ. Π§Π΅ΡΠ΅Π· 24 ΠΌΠ΅Ρ. Π½Π°Π±Π»ΡΠ΄Π΅Π½ΠΈΡ Π²ΡΠ΅ ΠΏΠ°ΡΠΈΠ΅Π½ΡΡ Ρ Π₯Π‘Π ΡΠ°Π·Π΄Π΅Π»Π΅Π½Ρ Π½Π° Π΄Π²Π΅ Π³ΡΡΠΏΠΏΡ: 1-Ρ Π³ΡΡΠΏΠΏΠ° β ΠΆΠ΅Π½ΡΠΈΠ½Ρ Ρ Π½Π΅Π±Π»Π°Π³ΠΎΠΏΡΠΈΡΡΠ½ΡΠΌ ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ΠΌ Π₯Π‘Π (n = 54), 2-Ρ Π³ΡΡΠΏΠΏΠ° β Ρ Π±Π»Π°Π³ΠΎΠΏΡΠΈΡΡΠ½ΡΠΌ ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ΠΌ ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΠΈ (n = 60). ΠΡΠΈΡΠ΅ΡΠΈΠΈ Π½Π΅Π±Π»Π°Π³ΠΎΠΏΡΠΈΡΡΠ½ΠΎΠ³ΠΎ ΡΠ΅ΡΠ΅Π½ΠΈΡ Π₯Π‘Π: ΠΏΠΎΡΠ²Π»Π΅Π½ΠΈΠ΅ Π½ΠΎΠ²ΡΡ
ΠΈΠ»ΠΈ ΡΡ
ΡΠ΄ΡΠ΅Π½ΠΈΠ΅ ΠΈΠΌΠ΅ΡΡΠΈΡ
ΡΡ ΡΠΈΠΌΠΏΡΠΎΠΌΠΎΠ²/ΠΏΡΠΈΠ·Π½Π°ΠΊΠΎΠ² Π‘Π ΠΈ/ΠΈΠ»ΠΈ Π³ΠΎΡΠΏΠΈΡΠ°Π»ΠΈΠ·Π°ΡΠΈΡ Π²ΡΠ»Π΅Π΄ΡΡΠ²ΠΈΠ΅ Π΄Π΅ΠΊΠΎΠΌΠΏΠ΅Π½ΡΠ°ΡΠΈΠΈ Π‘Π; ΡΠ½ΠΈΠΆΠ΅Π½ΠΈΠ΅ ΡΡΠ°ΠΊΡΠΈΠΈ Π²ΡΠ±ΡΠΎΡΠ° Π»Π΅Π²ΠΎΠ³ΠΎ ΠΆΠ΅Π»ΡΠ΄ΠΎΡΠΊΠ° Π±ΠΎΠ»Π΅Π΅ 10% ΠΈΠ»ΠΈ ΡΠ²Π΅Π»ΠΈΡΠ΅Π½ΠΈΠ΅ ΡΡΠ½ΠΊΡΠΈΠΎΠ½Π°Π»ΡΠ½ΠΎΠ³ΠΎ ΠΊΠ»Π°ΡΡΠ° Π₯Π‘Π Π½Π° ΠΎΠ΄ΠΈΠ½ ΠΈΠ»ΠΈ Π±ΠΎΠ»Π΅Π΅. ΠΡΡ
ΠΎΠ΄Π½ΡΠ΅ ΡΡ
ΠΎΠΊΠ°ΡΠ΄ΠΈΠΎΠ³ΡΠ°ΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΏΠ°ΡΠ°ΠΌΠ΅ΡΡΡ ΠΈ Π·Π½Π°ΡΠ΅Π½ΠΈΡ NT-proBNP Π½Π΅ ΡΠ°Π·Π»ΠΈΡΠ°Π»ΠΈΡΡ ΠΌΠ΅ΠΆΠ΄Ρ Π³ΡΡΠΏΠΏΠ°ΠΌΠΈ. Π£ΡΠΎΠ²Π΅Π½Ρ MMΠ-2 Π±ΡΠ» Π²ΡΡΠ΅ Π½Π° 8% (p = 0,017), MMΠ-9 Π½Π° β 18,4% (p<0,001) Π² Π³ΡΡΠΏΠΏΠ΅ 1 Π² ΡΡΠ°Π²Π½Π΅Π½ΠΈΠΈ Ρ Π³ΡΡΠΏΠΏΠΎΠΉ 2. Π’Π°ΠΊΠΆΠ΅ Π² 1-ΠΉ Π³ΡΡΠΏΠΏΠ΅ ΡΡΠΎΠ²Π΅Π½Ρ ΠΠΠ-2 ΡΠ½ΠΈΠ·ΠΈΠ»ΡΡ ΡΠ΅ΡΠ΅Π· 24 ΠΌΠ΅Ρ. Π½Π°Π±Π»ΡΠ΄Π΅Π½ΠΈΡ, Π²ΠΎ 2-ΠΉ Π³ΡΡΠΏΠΏΠ΅, Π½Π°ΠΏΡΠΎΡΠΈΠ², ΡΠ²Π΅Π»ΠΈΡΠΈΠ»ΡΡ ΠΊ ΠΊΠΎΠ½ΡΡ ΠΏΠ΅ΡΠΈΠΎΠ΄Π° Π½Π°Π±Π»ΡΠ΄Π΅Π½ΠΈΡ. Π£ΡΠΎΠ²Π½ΠΈ ΠΠΠ-2 β₯388,2 ΠΏΠ³/ΠΌΠ» (ΡΡΠ²ΡΡΠ²ΠΈΡΠ΅Π»ΡΠ½ΠΎΡΡΡ 46%, ΡΠΏΠ΅ΡΠΈΡΠΈΡΠ½ΠΎΡΡΡ 80%, AUΠ‘ = 0,64; p = 0,013) ΠΈ ΠΠΠ-9 β₯21,3 ΠΏΠ³/ΠΌΠ» (ΡΡΠ²ΡΡΠ²ΠΈΡΠ΅Π»ΡΠ½ΠΎΡΡΡ 86%, ΡΠΏΠ΅ΡΠΈΡΠΈΡΠ½ΠΎΡΡΡ 84,4%, AUΠ‘ = 0,9; Ρ<0,001) ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½Ρ ΠΊΠ°ΠΊ ΠΏΡΠ΅Π΄ΠΈΠΊΡΠΎΡΡ Π½Π΅Π±Π»Π°Π³ΠΎΠΏΡΠΈΡΡΠ½ΠΎΠ³ΠΎ ΡΠ΅ΡΠ΅Π½ΠΈΡ Π₯Π‘Π.ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅. Π Π΅ΠΌΠΎΠ΄Π΅Π»ΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ Π²Π½Π΅ΠΊΠ»Π΅ΡΠΎΡΠ½ΠΎΠ³ΠΎ ΠΌΠ°ΡΡΠΈΠΊΡΠ° ΠΌΠΎΠΆΠ΅Ρ ΠΈΠ³ΡΠ°ΡΡ Π²Π°ΠΆΠ½ΡΡ ΡΠΎΠ»Ρ Π² ΠΏΠ°ΡΠΎΠ³Π΅Π½Π΅Π·Π΅ Π₯Π‘Π, ΠΈΠ½ΠΈΡΠΈΠΈΡΡΠ΅ΠΌΠΎΠΉ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠ°ΠΌΠΈ ΠΊΠ»Π°ΡΡΠ° Π°Π½ΡΡΠ°ΡΠΈΠΊΠ»ΠΈΠ½ΠΎΠ². ΠΠΎΠ²ΡΡΠ΅Π½Π½ΡΠ΅ ΡΡΠΎΠ²Π½ΠΈ MMΠ-2 ΠΈ MMΠ-9 Π² ΡΡΠ²ΠΎΡΠΎΡΠΊΠ΅ ΠΊΡΠΎΠ²ΠΈ Π°ΡΡΠΎΡΠΈΠΈΡΠΎΠ²Π°Π½Ρ Ρ Π½Π΅Π±Π»Π°Π³ΠΎΠΏΡΠΈΡΡΠ½ΡΠΌ ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ΠΌ Π°Π½ΡΡΠ°ΡΠΈΠΊΠ»ΠΈΠ½ΠΈΠ½Π΄ΡΡΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠΉ Π₯Π‘Π ΠΈ ΠΌΠΎΠ³ΡΡ Π±ΡΡΡ ΡΠ΅ΠΊΠΎΠΌΠ΅Π½Π΄ΠΎΠ²Π°Π½Ρ ΠΏΡΠΈ ΠΎΡΠ΅Π½ΠΊΠ΅ ΡΠΈΡΠΊΠ° Π½Π΅Π±Π»Π°Π³ΠΎΠΏΡΠΈΡΡΠ½ΠΎΠ³ΠΎ ΠΏΡΠΎΠ³Π½ΠΎΠ·Π°
Wien filter using in exploring on low-energy radioactive nuclei
The possibility of using the Wien filter as a mass separator for the neutron enriched nuclei study is under discussion. The nuclei are produced as a result of sup 2 sup 3 sup 8 U fission within the frame of the 'DRIBs' project. The main ion-optics characteristics of the Wien filter are obtained using the moment method. Parameter optimization has been fulfilled to obtain the maximum resolution. The ion beam dynamics and heavy ion separation have been illustrated using the macroparticle simulation for the chosen optimal filter parameter. It is shown that the resolution can be obtained on the level higher than 10 sup 2. It provides an effective separation of the fission fragments with the high atomic number
The protecting effect of L-carnitine on Ca(2+)-loaded rat liver mitochondria
It is shown that L-carnitine strongly increases the ability of rat liver mitochondria to respond to the train of Ca2+ additions by a transient stimulation of the State-4 respiration rate. Such an effect requires ATP and the L-carnitine efficiency strongly decreases when ATP is omitted. Oleate influences the mitochondria in a fashion opposite to that of L-carnitine. The oleate effect is strongly diminished by L-carnitine. Again, the L-carnitine effect requires ATP, and D-carnitine fails to substitute for L-carnitine. It is suggested that L-carnitine removes, in an ATP-dependent manner, endogenous or added fatty acids, which are involved in oxidative damage of Ca(2+)-loaded mitochondria
Interaction of carnitine with mitochondrial cardiolipin
The physiological role of L-carnitine is to determine the transport of acyl-CoA through the mitochondrial membrane. However, some observations may also suggest a direct effect of the molecule per se on the physical properties of the membrane, most probably at the level of the binding site. This possibility has been investigated by studying the influence of adriamycin, a drug that binds to cardiolipin, on the effect of carnitine on isolated rat liver mitochondria. It has been found that adriamycin almost abolishes the activating effect of carnitine on state 2 respiration. The effect and its inhibition is seen by using either the L-form of carnitine or the D-form or both. Cardiolipin removes the effect of adriamycin and restores the activation by carnitine. It is proposed that some effects of carnitine on mitochondrial properties may be the result of interaction of carnitine with cardiolipin at the membrane level
- β¦